Leukocyte Reduction System

why choose Impactlife?

Unlock the potential of your research with our high-quality mononuclear cells—highly viable lymphocytes and monocytes harvested during plateletpheresis collections. Ideal for a range of research and preclinical applications, our cells offer the quality and reliability you can trust to elevate your results.

product specifications

0.5-3.2 x 10^9 Cells
Lymphocytes: 70-75% (45% T-Cells)
Monocytes: 20-25%
Granulocytes: <5%

Shipped Fresh (20-24° C) or Refrigerated (1-10° C) up to 3 days with donor testing results.

Research Applications

IMMUNOLOGY STUDIES

LRS cones/chambers yield abundant lymphocytes (T cells, B cells, NK cells) and monocytes, enabling studies on immune cell function, signaling pathways, and interactions.

INFECTIOUS DISEASE MODELING

Primary human leukocytes from LRS cones/chambers can be used to study host-pathogen interactions, immune responses, and drug screening against various infectious agents.

STEM CELL RESEARCH

LRS cones/chambers have been reported to contain a small population of endothelial progenitor cells and CD34+ stem cells, enabling research in stem cell biology and regenerative medicine.

CELL THERAPY AND REGENERATIVE MEDICINE RESEARCH

The high viability and functional capabilities of cells from LRS cones/chambers make them suitable for developing cell-based therapies and studying cellular processes involved in tissue regeneration.

DRUG SCREENING AND TOXICOLOGY TESTING

The availability of different leukocyte subsets from LRS cones/chambers allows for evaluating the efficacy and toxicity of drug candidates on relevant primary human cell types.

the answer is within us

ImpactLife delivers high-quality cellular products. From donor recruitment to cell processing and delivery, our comprehensive approach ensures reliability and precision at every step.

Safety

safety ImpactLife ensures a stringent level of safety in collecting a research leukopak for further manufacturing through rigorous donor screening, FDA-compliant procedures, and adherence to Institutional Review Board (IRB) guidelines.

Access

access ImpactLife ensures streamlined access to thousands of screened donors for research or cGMP-compliant leukopak collection through strategically located collection centers, comprehensive donor outreach programs, and efficient scheduling processes, facilitating a seamless and responsive donation experience.

Quality

quality ImpactLife maintains a high standard of quality in collecting a research or cGMP-compliant leukopak through meticulous donor selection, state-of-the-art equipment, and adherence to regulatory standards, ensuring the reliability and efficacy of the collected materials.

Personalization

personalization ImpactLife offers personalized research or cGMP-compliant leukopak collections through tailored donor recruitment strategies, customizable collection protocols, and cell characterization specifications, ensuring that each collection meets the specific needs and requirements of the client's research or therapeutic development.